These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3295020)

  • 21. Lactitol or lactulose in the treatment of chronic constipation: result of a systematic.
    Maydeo A
    J Indian Med Assoc; 2010 Nov; 108(11):789-92. PubMed ID: 21510584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the laxative effect of Lactitol as opposed to lactulose in an open, randomized comparative study].
    Heitland W; Mauersberger H
    Schweiz Rundsch Med Prax; 1988 May; 77(18):493-5. PubMed ID: 3051260
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
    Fehér J; Prónai L
    Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy.
    Salerno F; Moser P; Maggi A; Vitaliani G; Benetti G
    J Hepatol; 1994 Dec; 21(6):1092-6. PubMed ID: 7699233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactitol, a second-generation disaccharide for treatment of chronic portal-systemic encephalopathy. A double-blind, crossover, randomized clinical trial.
    Uribe M; Toledo H; Perez F; Vargas F; Gil S; Garcia-Ramos G; Ravelli GP; Guevara L
    Dig Dis Sci; 1987 Dec; 32(12):1345-53. PubMed ID: 3319453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study.
    Loguercio C; Del Vecchio Blanco C; Coltorti M
    J Int Med Res; 1987; 15(6):335-43. PubMed ID: 3125077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
    Conn HO; Leevy CM; Vlahcevic ZR; Rodgers JB; Maddrey WC; Seeff L; Levy LL
    Gastroenterology; 1977 Apr; 72(4 Pt 1):573-83. PubMed ID: 14049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials.
    Als-Nielsen B; Gluud LL; Gluud C
    BMJ; 2004 May; 328(7447):1046. PubMed ID: 15054035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
    Scevola D; Zambelli A; Concia E; Perversi L; Candiani C
    Clin Ter; 1989 Apr; 129(2):105-11. PubMed ID: 2525995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
    Mas A; Rodés J; Sunyer L; Rodrigo L; Planas R; Vargas V; Castells L; Rodríguez-Martínez D; Fernández-Rodríguez C; Coll I; Pardo A;
    J Hepatol; 2003 Jan; 38(1):51-8. PubMed ID: 12480560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactitol.
    Lancet; 1987 Jul; 2(8550):81-2. PubMed ID: 2885579
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A; Okada T; Ito T; Karube H; Nomoto T; Mizuno T; Shindo K
    Gut; 1990 Jun; 31(6):702-6. PubMed ID: 2199349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients.
    Riggio O; Varriale M; Testore GP; Di Rosa R; Di Rosa E; Merli M; Romiti A; Candiani C; Capocaccia L
    J Clin Gastroenterol; 1990 Aug; 12(4):433-6. PubMed ID: 2398251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lactitol in chronic idiopathic constipation in children].
    Pitzalis G; Deganello F; Mariani P; Chiarini-Testa MB; Virgilii F; Gasparri R; Calvani L; Bonamico M
    Pediatr Med Chir; 1995; 17(3):223-6. PubMed ID: 7567643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other?
    Capocaccia L; Riggio O
    Hepatology; 1990 Aug; 12(2):368-70. PubMed ID: 2391075
    [No Abstract]   [Full Text] [Related]  

  • 36. Lactulose syrup assessed in a double-blind study of elderly constipated patients.
    Sanders JF
    J Am Geriatr Soc; 1978 May; 26(5):236-9. PubMed ID: 346631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.
    Atterbury CE; Maddrey WC; Conn HO
    Am J Dig Dis; 1978 May; 23(5):398-406. PubMed ID: 354373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M; Naidoo K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of lactitol in the treatment of intestinal stasis in childhood].
    Martino AM; Pesce F; Rosati U
    Minerva Pediatr; 1992 Jun; 44(6):319-23. PubMed ID: 1635534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation.
    Masini A; Efrati C; Merli M; Attili AF; Amodio P; Ceccanti M; Riggio O
    Am J Gastroenterol; 1999 Nov; 94(11):3323-7. PubMed ID: 10566738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.